CCL3 and Alzheimer disease: Some authors have demonstrated a reduction of both pro-inflammatory and anti-inflammatory cytokines, hence assuming a general impairment of immune functions in AD patients, whereas others have demonstrated a decrease of IL-10, an increase of MIP1-α and an increase of IFN-γ, respectively [74,78,82,88].